CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −24,799 | $22.22 | $551K | 177,184 |
| 2026-03-11 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −1,097 | $17.03 | $19K | 201,983 |
| 2026-03-09 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −1,036 | $16.95 | $18K | 203,663 |
| 2026-03-09 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −583 | $16.95 | $10K | 203,080 |
| 2026-03-02 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −3,301 | $16.20 | $53K | 205,574 |
| 2026-03-02 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −875 | $16.20 | $14K | 204,699 |
| 2026-03-01 | Estepan Ian Michael Chief Operating Officer | Exercise or conversion | +8,125 | 208,875 | ||
| 2026-03-01 | Estepan Ian Michael Chief Operating Officer | Exercise or conversion · Performance Stock Units | −8,125 | 0 | ||
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Exercise or conversion | +2,069 | $13.71 | $28K | 195,369 |
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Exercise or conversion | +5,381 | $13.71 | $74K | 200,750 |
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −2,069 | 0 | ||
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −5,381 | 0 | ||
| 2026-02-25 | Estepan Ian Michael Chief Operating Officer | Grant or award · Performance Stock Units | +1,875 | 8,125 | ||
| 2025-12-16 | Estepan Ian Michael Chief Operating Officer | Sale | −13,187 | $22.31 | $294K | 193,300 |
| 2025-09-03 | Estepan Ian Michael Chief Operating Officer | Grant or award | +93,875 | 156,487 | ||
| 2025-09-03 | Estepan Ian Michael Chief Operating Officer | Grant or award | +50,000 | 206,487 | ||
| 2025-08-05 | Estepan Ian Michael Chief Operating Officer | Grant or award · Performance Stock Units | +6,250 | 6,250 | ||
| 2025-03-10 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −1,051 | $100.13 | $105K | 57,226 |
| 2025-03-10 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −2,890 | $100.13 | $289K | 54,336 |
| 2025-03-10 | Estepan Ian Michael Chief Financial Officer | Grant or award | +8,276 | 62,612 |
Page 1 of 4 · 66 trades